United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Ethypharm expands Mesalazine portfolio with strategic acquisition in China Ethypharm, a global leader in essential medicines for central nervous system disorders, hospital care, and internal medicine, has… byPallavi MadhirajuJune 15, 2024